Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
21 07 2020
Historique:
received: 10 03 2020
revised: 30 04 2020
accepted: 26 06 2020
entrez: 23 7 2020
pubmed: 23 7 2020
medline: 29 4 2021
Statut: ppublish

Résumé

Spatiotemporal control of Wnt/β-catenin signaling is critical for organism development and homeostasis. The poly-(ADP)-ribose polymerase Tankyrase (TNKS1) promotes Wnt/β-catenin signaling through PARylation-mediated degradation of AXIN1, a component of the β-catenin destruction complex. Although Wnt/β-catenin is a niche-restricted signaling program, tissue-specific factors that regulate TNKS1 are not known. Here, we report prostate-associated gene 4 (PAGE4) as a tissue-specific TNKS1 inhibitor that robustly represses canonical Wnt/β-catenin signaling in human cells, zebrafish, and mice. Structural and biochemical studies reveal that PAGE4 acts as an optimal substrate decoy that potently hijacks substrate binding sites on TNKS1 to prevent AXIN1 PARylation and degradation. Consistently, transgenic expression of PAGE4 in mice phenocopies TNKS1 knockout. Physiologically, PAGE4 is selectively expressed in stromal prostate fibroblasts and functions to establish a proper Wnt/β-catenin signaling niche through suppression of autocrine signaling. Our findings reveal a non-canonical mechanism for TNKS1 inhibition that functions to establish tissue-specific control of the Wnt/β-catenin pathway.

Identifiants

pubmed: 32698014
pii: S2211-1247(20)30903-7
doi: 10.1016/j.celrep.2020.107922
pii:
doi:

Substances chimiques

AXIN1 protein, human 0
Antigens, Neoplasm 0
Axin Protein 0
PAGE4 protein, human 0
Tankyrases EC 2.4.2.30

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

107922

Subventions

Organisme : CIHR
ID : PJT374609
Pays : Canada
Organisme : NIGMS NIH HHS
ID : P30 GM124165
Pays : United States
Organisme : NIH HHS
ID : S10 OD021527
Pays : United States

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests P.R.P. is a paid consultant for Levo Therapeutics, Inc., and Amgen, Inc.

Auteurs

Sajjan Koirala (S)

Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Jonathon Klein (J)

Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Yumei Zheng (Y)

Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Nicole O Glenn (NO)

Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Biology, Belmont University, Nashville, TN, USA.

Travis Eisemann (T)

Department of Biochemistry and Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

Klementina Fon Tacer (K)

Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Darcie J Miller (DJ)

Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Ozlem Kulak (O)

Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Meifen Lu (M)

Veterinary Pathology Core, St. Jude Children's Research Hospital, Memphis, TN, USA.

David B Finkelstein (DB)

Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Geoffrey Neale (G)

Hartwell Center, St. Jude Children's Research Hospital, Memphis, TN, USA.

Heather Tillman (H)

Veterinary Pathology Core, St. Jude Children's Research Hospital, Memphis, TN, USA.

Peter Vogel (P)

Veterinary Pathology Core, St. Jude Children's Research Hospital, Memphis, TN, USA.

Douglas W Strand (DW)

Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Lawrence Lum (L)

Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Pfizer, La Jolla, CA, USA.

Chad A Brautigam (CA)

Departments of Biophysics and Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

John M Pascal (JM)

Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada.

Wilson K Clements (WK)

Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Patrick Ryan Potts (PR)

Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: ryan.potts@stjude.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH